BIOMAT Database Logo BIOMAT Database Logo

Synthesis, structure-activity relationship and crystallographic studies of 3-substituted indolin-2-one RET inhibitors. 2010

Luca Mologni, and Roberta Rostagno, and Stefania Brussolo, and Phillip P Knowles, and Svend Kjaer, and Judith Murray-Rust, and Enrico Rosso, and Alfonso Zambon, and Leonardo Scapozza, and Neil Q McDonald, and Vittorio Lucchini, and Carlo Gambacorti-Passerini
Department of Clinical Medicine and Prevention, University of Milano-Bicocca, Monza, Italy. luca.mologni@unimib.it

The synthesis, structure-activity relationships (SAR) and structural data of a series of indolin-2-one inhibitors of RET tyrosine kinase are described. These compounds were designed to explore the available space around the indolinone scaffold within RET active site. Several substitutions at different positions were tested and biochemical data were used to draw a molecular model of steric and electrostatic interactions, which can be applied to design more potent and selective RET inhibitors. The crystal structures of RET kinase domain in complex with three inhibitors were solved. All three compounds bound in the ATP pocket and formed two hydrogen bonds with the kinase hinge region. Crystallographic analysis confirmed predictions from molecular modelling and helped refine SAR results. These data provide important information for the development of indolinone inhibitors for the treatment of RET-driven cancers.

UI MeSH Term Description Entries
D007211 Indoles Benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to ISOINDOLES which have the nitrogen away from the six-membered ring.
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D006860 Hydrogen Bonding A low-energy attractive force between hydrogen and another element. It plays a major role in determining the properties of water, proteins, and other compounds. Hydrogen Bonds,Bond, Hydrogen,Hydrogen Bond
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D051096 Proto-Oncogene Proteins c-ret Receptor protein-tyrosine kinases involved in the signaling of GLIAL CELL-LINE DERIVED NEUROTROPHIC FACTOR ligands. They contain an extracellular cadherin domain and form a receptor complexes with GDNF RECEPTORS. Mutations in ret protein are responsible for HIRSCHSPRUNG DISEASE and MULTIPLE ENDOCRINE NEOPLASIA TYPE 2. c-ret Protein,ret Proto-Oncogene Proteins,Proto-Oncogene Protein Ret,Proto-Oncogene Protein c-ret,Receptor Tyrosine Kinase RET,Proto Oncogene Protein Ret,Proto Oncogene Protein c ret,Proto Oncogene Proteins c ret,Proto-Oncogene Proteins, ret,Ret, Proto-Oncogene Protein,c-ret, Proto-Oncogene Protein,c-ret, Proto-Oncogene Proteins,ret Proto Oncogene Proteins
D018360 Crystallography, X-Ray The study of crystal structure using X-RAY DIFFRACTION techniques. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) X-Ray Crystallography,Crystallography, X Ray,Crystallography, Xray,X Ray Crystallography,Xray Crystallography,Crystallographies, X Ray,X Ray Crystallographies
D021241 Spectrometry, Mass, Electrospray Ionization A mass spectrometry technique used for analysis of nonvolatile compounds such as proteins and macromolecules. The technique involves preparing electrically charged droplets from analyte molecules dissolved in solvent. The electrically charged droplets enter a vacuum chamber where the solvent is evaporated. Evaporation of solvent reduces the droplet size, thereby increasing the coulombic repulsion within the droplet. As the charged droplets get smaller, the excess charge within them causes them to disintegrate and release analyte molecules. The volatilized analyte molecules are then analyzed by mass spectrometry. ESI Mass Spectrometry,Electrospray Ionization Mass Spectrometry,Mass Spectrometry, ESI,Spectrometry, ESI Mass

Related Publications

Luca Mologni, and Roberta Rostagno, and Stefania Brussolo, and Phillip P Knowles, and Svend Kjaer, and Judith Murray-Rust, and Enrico Rosso, and Alfonso Zambon, and Leonardo Scapozza, and Neil Q McDonald, and Vittorio Lucchini, and Carlo Gambacorti-Passerini
Synthesis and structure-activity relationship studies of 3-substituted indolin-2-ones as effective neuroprotective agents.
November 2008, Experimental biology and medicine (Maywood, N.J.),
Luca Mologni, and Roberta Rostagno, and Stefania Brussolo, and Phillip P Knowles, and Svend Kjaer, and Judith Murray-Rust, and Enrico Rosso, and Alfonso Zambon, and Leonardo Scapozza, and Neil Q McDonald, and Vittorio Lucchini, and Carlo Gambacorti-Passerini
Design, synthesis, structure-activity relationships study and X-ray crystallography of 3-substituted-indolin-2-one-5-carboxamide derivatives as PAK4 inhibitors.
July 2018, European journal of medicinal chemistry,
Luca Mologni, and Roberta Rostagno, and Stefania Brussolo, and Phillip P Knowles, and Svend Kjaer, and Judith Murray-Rust, and Enrico Rosso, and Alfonso Zambon, and Leonardo Scapozza, and Neil Q McDonald, and Vittorio Lucchini, and Carlo Gambacorti-Passerini
Synthesis and RET protein kinase inhibitory activity of 3-arylureidobenzylidene-indolin-2-ones.
July 2007, Bioorganic & medicinal chemistry letters,
Luca Mologni, and Roberta Rostagno, and Stefania Brussolo, and Phillip P Knowles, and Svend Kjaer, and Judith Murray-Rust, and Enrico Rosso, and Alfonso Zambon, and Leonardo Scapozza, and Neil Q McDonald, and Vittorio Lucchini, and Carlo Gambacorti-Passerini
Structure-activity relationship studies of indolin-2-one derivatives as vascular endothelial growth factor receptor inhibitors and anticancer agents.
December 2020, Archiv der Pharmazie,
Luca Mologni, and Roberta Rostagno, and Stefania Brussolo, and Phillip P Knowles, and Svend Kjaer, and Judith Murray-Rust, and Enrico Rosso, and Alfonso Zambon, and Leonardo Scapozza, and Neil Q McDonald, and Vittorio Lucchini, and Carlo Gambacorti-Passerini
Synthesis and biological evaluation of 3-substituted-indolin-2-one derivatives containing chloropyrrole moieties.
November 2011, Molecules (Basel, Switzerland),
Luca Mologni, and Roberta Rostagno, and Stefania Brussolo, and Phillip P Knowles, and Svend Kjaer, and Judith Murray-Rust, and Enrico Rosso, and Alfonso Zambon, and Leonardo Scapozza, and Neil Q McDonald, and Vittorio Lucchini, and Carlo Gambacorti-Passerini
Indolin-2-one p38α inhibitors I: design, profiling and crystallographic binding mode.
July 2011, Bioorganic & medicinal chemistry letters,
Luca Mologni, and Roberta Rostagno, and Stefania Brussolo, and Phillip P Knowles, and Svend Kjaer, and Judith Murray-Rust, and Enrico Rosso, and Alfonso Zambon, and Leonardo Scapozza, and Neil Q McDonald, and Vittorio Lucchini, and Carlo Gambacorti-Passerini
Synthesis of bis(2-methyl-2-indolin-3-one).
August 1956, Pharmaceutical bulletin,
Luca Mologni, and Roberta Rostagno, and Stefania Brussolo, and Phillip P Knowles, and Svend Kjaer, and Judith Murray-Rust, and Enrico Rosso, and Alfonso Zambon, and Leonardo Scapozza, and Neil Q McDonald, and Vittorio Lucchini, and Carlo Gambacorti-Passerini
Novel N-substituted 5-phosphate-d-arabinonamide derivatives as strong inhibitors of phosphoglucose isomerases: Synthesis, structure-activity relationship and crystallographic studies.
September 2020, Bioorganic chemistry,
Luca Mologni, and Roberta Rostagno, and Stefania Brussolo, and Phillip P Knowles, and Svend Kjaer, and Judith Murray-Rust, and Enrico Rosso, and Alfonso Zambon, and Leonardo Scapozza, and Neil Q McDonald, and Vittorio Lucchini, and Carlo Gambacorti-Passerini
The Development of 3-substituted Indolin-2-one Derivatives as Kinase Inhibitors for Cancer Therapy.
January 2022, Current medicinal chemistry,
Luca Mologni, and Roberta Rostagno, and Stefania Brussolo, and Phillip P Knowles, and Svend Kjaer, and Judith Murray-Rust, and Enrico Rosso, and Alfonso Zambon, and Leonardo Scapozza, and Neil Q McDonald, and Vittorio Lucchini, and Carlo Gambacorti-Passerini
Substituted indolin-2-ones as p90 ribosomal S6 protein kinase 2 (RSK2) inhibitors: Molecular docking simulation and structure-activity relationship analysis.
April 2013, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!